Simplicity Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.6M Buy
81,682
+38,842
+91% +$8.36M 0.69% 25
2026
Q1
$9.32M Buy
42,840
+11,328
+36% +$2.51M 0.53% 38
2025
Q4
$7.2M Buy
31,512
+1,300
+4% +$296K 0.43% 50
2025
Q3
$7M Sell
30,212
-25,039
-45% -$5.1M 0.41% 50
2025
Q2
$10.3M Buy
55,251
+35,208
+176% +$6.54M 0.43% 47
2025
Q1
$4.2M Buy
20,043
+14,576
+267% +$2.83M 0.33% 67
2024
Q4
$971K Sell
5,467
-8,972
-62% -$1.65M 0.2% 94
2024
Q3
$2.85M Sell
14,439
-120,096
-89% -$22.4M 0.26% 86
2024
Q2
$23.1M Buy
134,535
+13,608
+11% +$2.25M 0.52% 33
2024
Q1
$21.8M Buy
120,927
+119,550
+8,682% +$20.6M 0.52% 28
2023
Q4
$213K Buy
+1,377
New +$201K 0.08% 170

Other funds holding ABBV

Simplicity Wealth's ABBV Position: Q2 2026 in Review

Simplicity Wealth increased its AbbVie (ABBV) stake by 91% in Q2 2026, buying an estimated $8.36M and bringing the position to 81,682 shares worth $20.6M. The position accounts for 0.69% of the portfolio, ranked #25.

Simplicity Wealth first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $23.1M in Q2 2024. 4,214 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Simplicity Wealth held 81,682 shares of AbbVie worth $20.6M as of Q2 2026.
  • Simplicity Wealth bought 38,842 AbbVie shares in Q2 2026, an estimated $8.36M.
  • AbbVie made up 0.69% of Simplicity Wealth's portfolio in Q2 2026, its #25 holding.
  • Simplicity Wealth first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • Simplicity Wealth's AbbVie position peaked at $23.1M in Q2 2024.
  • 4,214 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.